Sumitomo Mitsui Trust Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 156,657 shares of IONS stock, worth $5.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,657
Previous 196,114
20.12%
Holding current value
$5.15 Million
Previous $7.86 Million
30.3%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding IONS
# of Institutions
408Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$495 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$466 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$339 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$287 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$259 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.67B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...